Effects of long-term high-altitude exposure on fibrinolytic system

Hematology. 2021 Dec;26(1):503-509. doi: 10.1080/16078454.2021.1946265.

Abstract

Objective: High altitude (HA), with the main feature of hypobaric hypoxia, is an independent risk factor for thrombosis. However, little is known on the alterations of fibrinolytic system in adaptation to HA. In this study, we investigated changes of fibrinolytic system parameters between individuals permanently living at HA and low altitude (LA) regions, and provided data for further studies on HA-induced thrombotic disease.

Material and methods: A total of 226 eligible participants, including 103 LA participants, 100 healthy HA subjects and 23 high altitude polycythemia (HAPC) patients, were recruited in this study. Six fibrinolytic parameters, i.e. fibrinogen (Fbg), D-dimer (DDi), antithrombin III (AT-III), plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and plasminogen (PLG) were analyzed respectively. PAI-1 and tPA were performed by using bio-immuno-assays and an automated coagulation analyzer was used to conduct Fbg, DDi, AT-III and PLG tests.

Results: Plasma levels of Fbg, DDi, PAI-1 and PLG were significantly higher in healthy HA group than in LA group (all p < 0.05), whereas tPA was significantly lower in healthy HA group. No significant difference in AT-III was observed between healthy HA and LA groups (p > 0.05). All these fibrinolytic parameters showed no significant distinctions between healthy HA subjects and HAPC patients (all p > 0.05). HGB showed no relationship with fibrinolytic parameters in HA cohort.

Conclusion: This study demonstrates that HA environment has a significant effect on fibrinolytic system and provides a foundation for further studies on HA hypobaric hypoxia-induced thrombotic disease.

Keywords: High altitude; fibrinolytic system; hemoglobin; red blood cells.

MeSH terms

  • Adult
  • Aged
  • Altitude*
  • Antithrombin III / analysis
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinogen / analysis
  • Fibrinolysis*
  • Humans
  • Male
  • Middle Aged
  • Thrombosis / blood
  • Thrombosis / etiology*
  • Young Adult

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Antithrombin III
  • Fibrinogen